We are committed to serving the needs of patients and physicians by providing access to therapeutic options and disease awareness.
Reaching people, changing lives
Our clinical team is highly experienced in the drug development process especially regarding lupus nephritis. Aurinia consists of members of the team from Isotechnika who discovered, developed and generated the substantial dataset that exists to date on voclosporin, and the Aspreva team who executed one of the largest and most successful studies (ALMS) performed to date in lupus nephritis. We work with patient advocacy groups, healthcare providers and researchers across the globe to support our mission of delivering treatments to people suffering from debilitating diseases.